Drug firm Suven Life Sciences today reported a 45 per cent dip in standalone net profit to Rs 17.71 crore for the third quarter ended December 31, 2015.
The company had posted a net profit of Rs 32.22 crore in the corresponding period of the previous fiscal, Suven Life Sciences said in a filing to BSE.
Standalone net sales of the company stood at Rs 112.50 crore for the quarter under review. It was Rs 128.82 crore for the same period a year ago.
Shares of Suven Life Sciences today closed at Rs 175.35 per scrip on BSE, down 9.05 per cent from the previous close.
